國泰全球基因免疫與醫療革命ETF基金

254900LB24CO5RQVWM38

The entity

Status: Active
LEI status: Issued and current
Category: Fund
Legal form: 8888
Jurisdiction: Taiwan
Entity created: September 1, 2021

Address

Country: Taiwan
Legal address: 17th Floor, No. 132, Sec. 3, Minsheng East Road, Songshan Dist.105402 TaipeiTaiwan (TW-TPE)
Head office: C/O Cathay Securities Investment Trust Co., Ltd., 17th Floor, No. 132, Sec. 3, Minsheng East Road, Songshan Dist.105402 TaipeiTaiwan (TW-TPE)

Identifier

LEI: 254900LB24CO5RQVWM38
Registered: November 4, 2021 at 01:34 AM UTC
Last updated: August 24, 2026 at 08:21 AM UTC
Next renewal: December 3, 2026 at 02:30 PM UTC
Issuer: Bloomberg (5493001KJTIIGC8Y1R12)
Registered with: Financial Supervisory Commission (FSC) (RA001009)
Identifier: 88237803
Verified against: Financial Supervisory Commission (FSC) (RA001009)
Verified as: 88237803
Corroboration: Confirmed against a public register
GLEIF conformity: Meets the standard

Corporate structure

Owned by

國泰證券投資信託股份有限公司
Fund managerTaiwan5493009O0G5TGPI5VZ81

Why no parent is reported

No direct parent reportedNo ultimate parent reported: No parent prepares consolidated accounts including it

Machine access

REST: https://lei.online/v1/entities/254900LB24CO5RQVWM38This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search